This review critically evaluates the limited evidence in support of angiotensin-converting enzyme inhibitors as renal-protective agents in people with type 2 diabetes.

National and international clinical guidelines do not consistently recommend treating nondiabetic proteinuric patients with advanced renal disease with an angiotensin-converting enzyme (ACE ...

Medically reviewed by Christopher Lee, MD Congestive heart failure (CHF), sometimes simply called heart failure, happens when ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Early diagnosis and treatment of hypertension, with drugs that block the renin–angiotensin ... longer renal survival and greater use of ACE inhibitors than those followed during the initial ...

China: A recent cohort study has suggested that sacubitril/valsartan may offer superior kidney function benefits for patients with thrombotic microangiopathy (TMA) associated with malignant ...

High blood pressure, also known as hypertension, doesn’t just strain your heart; it can also harm your kidneys. The ...

It can increase the risk for kidney-related side effects of NSAIDs and certain blood pressure medications Interaction explained: Celecoxib can make ACE inhibitors, ARBs, and beta blockers less ...

The global IgA Nephropathy Disease Treatment Market is at the forefront of addressing the growing burden of renal diseases worldwide. With a projected value surpassing USD 485 million by 2028, the ...

There probably is a small increased risk of heart attack and death from stimulants like amphetamine/dexamphetamine (Adderall) ...